A New Rapid-Response Strategy for Suicidal Depression? Stanford Researchers Explore Ketamine Followed by Buprenorphine | Reno, Nevada |

When suicidal thoughts become a psychiatric emergency, waiting weeks for traditional antidepressants may not be enough. A new Stanford study explores an emerging rapid-intervention strategy using IV ketamine followed by low-dose buprenorphine to help sustain anti-suicidal effects in patients with major depression. Here’s what the science says—and why this could represent a meaningful shift in interventional psychiatry.